moderate Atopic dermatitis (DBCOND0025271)

Identifiers

Synonyms
Moderate Atopic Dermatitis

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Abrocitinib
A kinase inhibitor used to treat moderate-to-severe atopic dermatitis in adults.
Baricitinib
A Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist.
Crisaborole
A non-steroidal topical medication used for the treatment of mild-moderate atopic dermatitis.
Desonide
A topical corticosteroid used for the symptomatic treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Dupilumab
A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults.
Fusidic acid
A topical antibacterial agent used to prevent and treat mild to moderate skin infections caused by susceptible bacteria.
Lebrikizumab
An IgG4 monoclonal antibody against IL-13 used to treat moderate-to-severe atopic dermatitis in adults and adolescents.
Pimecrolimus
A topical calcineurin inhibitor used in the treatment of mild-moderate atopic dermatitis who are not candidates for other types of therapy due to previous lack of response or other reasons.
Ruxolitinib
A kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment.
Tacrolimus
A calcineurin inhibitor used to prevent organ transplant rejection and to treat moderate to severe atopic dermatitis.
Clinical Trials
Not Available